Home
Resources
Product Analysis
Acknowledgements
About
Home
References
Business models
Business models
B2B
Products 131 to 140 of 162
Modify Display Properties
Biotech components
Business models
Country of production
Country of distribution
Intended consumer
Date added
Date last modified
Known funding amount
Funding types
Industry
Market status
Organization
Organization type(s)
Product categories
Production process
Source
Trading symbol
Value chain stage
Sort: Title (A-Z)
Date added (oldest-newest)
Date added (newest-oldest)
Date modified (oldest-newest)
Date modified (newest-oldest)
Title (A-Z)
Title (Z-A)
Organization (A-Z)
Organization (Z-A)
rHuPH20
by
Halozyme
Biotech components:
Enzyme
Business models:
B2B
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/10/01 09:37 (6 years ago)
Known funding amount:
N/A
Funding types:
Shareholder Investment
Industry:
Health
Market status:
On the market
Organization type(s):
Public Company
Product categories:
Medical Treatment
Production process:
Closed Production
Source:
NASEM Database
Trading symbol:
HALO
(NASDAQ)
Value chain stage:
Input
RNA-based Biocontrols
by
Syngenta
Biotech components:
Molecule
Business models:
B2B
Country of production:
Switzerland
Country of distribution:
Switzerland
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/10/02 11:25 (6 years ago)
Known funding amount:
2,147,483,647 USD
Funding types:
Shareholder Investment
Industry:
Food & Agriculture
Market status:
Under Development
Organization type(s):
Public Company
Product categories:
Plant
Production process:
Open Release
Source:
NASEM Database
Trading symbol:
SYT
(NYSE)
Value chain stage:
Input
Robotic Cloud Lab
by
Transcriptic
Biotech components:
N/A
Business models:
B2B
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Research
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/08/30 11:49 (6 years ago)
Known funding amount:
9,500,000 USD
Funding types:
Government
Industry:
Science
Market status:
On the market
Organization type(s):
Private Company
Product categories:
Design
Production process:
Open Release
Source:
Web search
Trading symbol:
N/A
Value chain stage:
Platform
Salt Tolerant Carrots
by
Salt Farm Texel
Biotech components:
Plant
Business models:
B2B
Country of production:
Netherlands
Country of distribution:
Netherlands
+
Pakistan
+
Bangladesh
+
Ghana
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/10/08 14:52 (6 years ago)
Known funding amount:
500,000 USD
Funding types:
Private Funding
Industry:
Food & Agriculture
Market status:
Under Development
Organization type(s):
Private Company
Product categories:
Plant
Production process:
Open Release
Source:
Web search
Trading symbol:
N/A
Value chain stage:
Finished Product
Salt Tolerant Potatoes
by
Salt Farm Texel
Biotech components:
Plant
Business models:
B2B
Country of production:
Netherlands
Country of distribution:
Netherlands
+
Pakistan
+
Bangladesh
+
Ghana
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/10/08 14:53 (6 years ago)
Known funding amount:
500,000 USD
Funding types:
Private Funding
Industry:
Food & Agriculture
Market status:
Under Development
Organization type(s):
Private Company
Product categories:
Plant
Production process:
Open Release
Source:
Web search
Trading symbol:
N/A
Value chain stage:
Finished Product
Salt Tolerant Tomatoes
by
Salt Farm Texel
Biotech components:
Plant
Business models:
B2B
Country of production:
Netherlands
Country of distribution:
Netherlands
+
Pakistan
+
Bangladesh
+
Ghana
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/10/08 14:52 (6 years ago)
Known funding amount:
500,000 USD
Funding types:
Private Funding
Industry:
Food & Agriculture
Market status:
Under Development
Organization type(s):
Private Company
Product categories:
Plant
Production process:
Open Release
Source:
Web search
Trading symbol:
N/A
Value chain stage:
Finished Product
Sanibel BLUE (#1)
by
Algenol
Biotech components:
Plant
Business models:
B2B
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2019/04/01 15:55 (5 years ago)
Known funding amount:
25,000,000 USD
Funding types:
Government
+
University
+
Venture Capital
Industry:
Food & Agriculture
Market status:
On the market
Organization type(s):
Private Company
Product categories:
Additive
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
N/A
Value chain stage:
Finished Product
Sabacic Acid
by
Verdezyne
Biotech components:
Plant
Business models:
B2B
Country of production:
USA
Country of distribution:
USA
+
Europe
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/11/08 14:47 (5 years ago)
Known funding amount:
86,500,000 USD
Funding types:
Venture Capital
Industry:
Industrial
Market status:
More information needed
+
No longer on the market
Organization type(s):
Private Company
Product categories:
Fiber
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
N/A
Value chain stage:
Input
SER150DN
by
Serodus
+
Evolva
Biotech components:
Molecule
Business models:
B2B
Country of production:
USA
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/11/09 16:29 (5 years ago)
Known funding amount:
102,000,000 NOK
Funding types:
Private Funding
Industry:
Health
Market status:
Under Development
+
More information needed
Organization type(s):
Private Company
Product categories:
Medical Treatment
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
N/A
Value chain stage:
Finished Product
Sitagliptin
by
Codexis
Biotech components:
Enzyme
Business models:
B2B
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/08/30 11:49 (6 years ago)
Known funding amount:
37,000,000 USD
Funding types:
Shareholder Investment
Industry:
Health
Market status:
Under Development
Organization type(s):
Public Company
Product categories:
Medical Treatment
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
CDXS
(NASDAQ)
Value chain stage:
Input
1
…
8
9
10
11
12
13
14
15
16
17
Login
or
register
to add and edit products
Future
Bioengineered
Products
Home
Resources
Product Analysis
Acknowledgements
About
